Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston reports good start for mid-urethral slings:

This article was originally published in Clinica

Executive Summary

Boston Scientific says early feedback on three new products to treat female stress urinary incontinence has been very positive. The products offer three different approaches for placing mid-urethral slings, which provide support on the pelvic floor. The Advantage system offers transvaginal delivery, the Lynx system is for supra-pubic placement and Obtryx enables placement laterally through the pelvis. All three are for use with Boston's Advantage Mesh sling. The company said the mid-urethral sling product market is worth $130m a year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060053

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel